Download video

The role of oxygen in ILDS patients | Dr. Agam Vora | LUNG Health |Sanrai Med India

58 views

Sanrai Med India

3 months ago

The role of oxygen in ILDS patients | Dr. Agam Vora | LUNG Health |Sanrai Med India

The role of oxygen in ILDS patients | Dr. Agam Vora | LUNG Health |Sanrai Med India

The role of oxygen in ILDS patients | Dr. Agam Vora | LUNG Health |Sanrai Med India
0:54
The role of oxygen in ILDS patients | Dr. Agam Vora | LUNG Health |Sanrai Med India
by Sanrai Med India
Proteasome inhibitors are ideal partners in combination oncolytic virus therapy
1:47
Proteasome inhibitors are ideal partners in combination oncolytic virus therapy
by AJE Video Bytes
Living Donor Liver Transplant Recipient | Advances Happen Here
0:31
Living Donor Liver Transplant Recipient | Advances Happen Here
by UR Medicine
Asvide: The right S¹a + S² + S⁶a segmentectomy for deep interlobar lung cancer with fused fissure.
5:54
Asvide: The right S¹a + S² + S⁶a segmentectomy for deep interlobar lung cancer with fused fissure.
by ASVIDE
Shaping Up Your Goniotomy with Dr. Lorraine M. Provencher @ASCRS 2024
9:40
Shaping Up Your Goniotomy with Dr. Lorraine M. Provencher @ASCRS 2024
by Media MICE
2024 09 25 Let's Code Together
1:33:41
2024 09 25 Let's Code Together
by MedDRA MSSO
The changing role of alloSCT in DLBCL in the era of novel agents
1:09
The changing role of alloSCT in DLBCL in the era of novel agents
by VJHemOnc – Video Journal of Hematology \& HemOnc
The potential of CELMoDs for the treatment of R\/R multiple myeloma
1:14
The potential of CELMoDs for the treatment of R\/R multiple myeloma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Quality of life improved after surgery for 55 y.o. | Parathyroid hyperplasia case study
7:19
Quality of life improved after surgery for 55 y.o. | Parathyroid hyperplasia case study
by LarianMD
Rheumatoid Arthritis ILD - Recent changes and update 2024
33:16
Rheumatoid Arthritis ILD - Recent changes and update 2024
by Pulmonology Read Aloud
Exciting new material for long-acting drug delivery
1:24
Exciting new material for long-acting drug delivery
by Institut Laue Langevin
Linvoseltamab induces deep and durable responses in patients with relapsed or refractory multipl...
7:32
Linvoseltamab induces deep and durable responses in patients with relapsed or refractory multipl...
by ecancer
An update from LIMBER-104: zilurgisertib +\/- ruxolitinib in the management of MF-associated anemia
2:21
An update from LIMBER-104: zilurgisertib +\/- ruxolitinib in the management of MF-associated anemia
by VJHemOnc – Video Journal of Hematology \& HemOnc
Four-year follow-up of GMMG-CONCEPT: efficacy of Isa-KRd in high-risk newly diagnosed myeloma
1:27
Four-year follow-up of GMMG-CONCEPT: efficacy of Isa-KRd in high-risk newly diagnosed myeloma
by VJHemOnc – Video Journal of Hematology \& HemOnc
OIS Drug Delivery Innovation Showcase - Re-Vana Therapeutics
7:11
OIS Drug Delivery Innovation Showcase - Re-Vana Therapeutics
by OIS: Ophthalmology Innovation Source
Updates in the treatment of R\/R LBCL: promising novel agents in the pipeline
1:18
Updates in the treatment of R\/R LBCL: promising novel agents in the pipeline
by VJHemOnc – Video Journal of Hematology \& HemOnc
2023 November Author Interview-Allon Kahn
7:03
2023 November Author Interview-Allon Kahn
by GIE: Gastrointestinal Endoscopy Author Interviews
Approaching R\/R multiple myeloma: novel agents and immunotherapies
1:37
Approaching R\/R multiple myeloma: novel agents and immunotherapies
by VJHemOnc – Video Journal of Hematology \& HemOnc
The role of glycoproteomics in cancer progression
0:55
The role of glycoproteomics in cancer progression
by VJOncology
The HIV Long Lived Reservoir: The Guest that Just Won't Leave
12:31
The HIV Long Lived Reservoir: The Guest that Just Won't Leave
by LearnToRELATE
Rheumatic Heart Disease, Severe MS, Grossly Dilated LA,LA auto contrast present, Thrombus present LA
0:17
Rheumatic Heart Disease, Severe MS, Grossly Dilated LA,LA auto contrast present, Thrombus present LA
by My Cardiology🫀
Overcoming resistance to trastuzumab deruxtecan in HER2-low cancers
1:42
Overcoming resistance to trastuzumab deruxtecan in HER2-low cancers
by VJOncology